Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT

[1]  J. Shah,et al.  NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  V. Treyer,et al.  A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET. , 2021, The British journal of radiology.

[3]  N. Rupp,et al.  Measurement variations of MRI and CT in the assessment of tumor depth of invasion in oral cancer: A retrospective study. , 2020, European journal of radiology.

[4]  Jeong Hyun Lee,et al.  The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis , 2020, European Radiology.

[5]  P. Boscolo-Rizzo,et al.  Extranodal extension in head and neck squamous cell cancer: is there a role for further stratification? , 2020, The British journal of oral & maxillofacial surgery.

[6]  N. Rupp,et al.  Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype , 2020, Frontiers in Oncology.

[7]  B. Judson,et al.  Prognostic Significance of Extranodal Extension in HPV-Mediated Oropharyngeal Carcinoma: A Systematic Review and Meta-analysis , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  N. Aygun,et al.  Computed tomography performance in predicting extranodal extension in HPV‐positive oropharynx cancer , 2020, The Laryngoscope.

[9]  H. Arimura,et al.  Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma , 2020, AntiCancer Research.

[10]  Bin Huang,et al.  Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[11]  C. Sachpekidis,et al.  Multimodal Imaging With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging to Detect Extracapsular Extension in Head and Neck Cancer , 2020, The Laryngoscope.

[12]  A. Dietz,et al.  Extracapsular extension of neck nodes and absence of human papillomavirus 16‐DNA are predictors of impaired survival in p16‐positive oropharyngeal squamous cell carcinoma , 2020, Cancer.

[13]  J. Waldron,et al.  Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  K. Fung,et al.  Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. , 2019, The Lancet. Oncology.

[15]  N. Rupp,et al.  Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suvmax) In Laryngeal and Hypopharyngeal Cancer , 2019, Scientific Reports.

[16]  J. Sonke,et al.  The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus–Positive Versus Human Papillomavirus–Negative Patients With Oropharyngeal Cancer , 2019, Clinical nuclear medicine.

[17]  S. Krishnan,et al.  Predictive value of computed tomography in identifying extracapsular spread of cervical lymph node metastases in p16 positive oropharyngeal squamous cell carcinoma , 2019, Journal of medical imaging and radiation oncology.

[18]  B. O'Sullivan,et al.  Radiologic-Pathologic Correlation of Extranodal Extension in Patients With Squamous Cell Carcinoma of the Oral Cavity: Implications for Future Editions of the TNM Classification. , 2018, International journal of radiation oncology, biology, physics.

[19]  S. Stoeckli,et al.  Maximum Standardized Uptake Value (SUVmax) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer , 2018, Scientific Reports.

[20]  B. O'Sullivan,et al.  Major Changes in Head and Neck Staging for 2018. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[21]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[22]  J. Contessa,et al.  The prognostic value of extranodal extension in human papillomavirus‐associated oropharyngeal squamous cell carcinoma , 2017, Cancer.

[23]  Piyush Jani,et al.  Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma. , 2016, The Cochrane database of systematic reviews.

[24]  G. Tolstonog,et al.  Extracapsular spread in head and neck squamous cell carcinoma: A systematic review and meta-analysis. , 2016, Oral oncology.

[25]  S. Stoeckli,et al.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma , 2015, Head & neck.

[26]  G. V. von Schulthess,et al.  Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations. , 2014, Radiology.

[27]  K. Ang,et al.  Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. , 2012, International journal of radiation oncology, biology, physics.

[28]  D. Elashoff,et al.  Cancer of unknown primary: Does treatment modality make a difference? , 2012, The Laryngoscope.

[29]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  G. Kubicek,et al.  FDG-PET staging and importance of lymph node SUV in head and neck cancer , 2010, Head & neck oncology.

[31]  S. Stoeckli.  Sentinel Node Biopsy for Oral and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck , 2007, The Laryngoscope.

[32]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[33]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[34]  R. Felix,et al.  Kapseldurchbrüche zervikaler Lymphknotenmetastasen: Diagnostischer Stellenwert der Computertomographie , 1999 .

[35]  Chad A. LaGrange,et al.  NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[36]  A. Beck,et al.  Kapseldurchbrüche zervikaler Lymphknotenmetastasen: Diagnostischer Stellenwert der Magnetresonanztomographie , 2002 .

[37]  R. Felix,et al.  [Extracapsular spread of cervical lymph node metastases: Diagnostic value of magnetic resonance imaging]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[38]  R. Felix,et al.  [The extracapsular spread of cervical lymph node metastases: the diagnostic value of computed tomography]. , 1999, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.